Company · CIK 0001526119 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Verastem, Inc. · VSTM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 SForm 4 → | Sep 23, 8:10 pm EDT | Daniel CalkinsChief Financial Officer | 55 | $7.70 | $424 | 118,014 | −0.05% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 4:37 pm EDT | Dan PatersonPresident and CEO, Director | 1,302 | $5.81 | $7,565 | 589,940 | −0.22% | 10b5-1 |
| Jun 22, 2026 SForm 4 → | Jun 24, 4:45 pm EDT | Dan PatersonPresident and CEO, Director | 20,871 | $4.18 | $87,241 | 591,242 | −3.41% | 10b5-1 |
| Jun 22, 2026 SForm 4 → | Jun 24, 4:44 pm EDT | Daniel CalkinsChief Financial Officer | 4,089 | $4.18 | $17,089 | 117,238 | −3.37% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.